X-tosis to Present at Seed Showcase 2025 Alongside the J.P. Morgan Annual Healthcare Conference
08 janv. 2025 12h57 HE
|
X-tosis
GAINESVILLE, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- X-tosis, Inc., a pre-clinical biotech company transforming the treatment of neurodegenerative and mitochondrial dysfunction-related diseases,...